Pharmacological reversal of behavioral and cellular indices of cocaine sensitization in the rat

Y. Li, F. J. White, Marina Wolf

Research output: Contribution to journalArticle

48 Citations (Scopus)

Abstract

Rationale and objectives: Behavioral sensitization has been proposed as an animal model for the intensification of drug craving in cocaine addiction. Interactions between dopamine and glutamate systems are important for the induction and maintenance of sensitization. The goal of this study was to determine if established cocaine sensitization could be reversed by pharmacological manipulation of these transmitter systems. Methods: Rats received 15 mg/kg cocaine (IP) on days 1-10 and were challenged with cocaine (10 mg/kg) on day 13 to verify that sensitization had occurred. On days 14-20, separate groups of sensitized rats received daily injections of dopamine D1- or D2-class agonists, an NMDA receptor antagonist, or a dopamine agonist with an NMDA antagonist. Three days or 2 weeks later, all rats were again tested for their response to cocaine to determine if sensitization had been reversed. Results: Reversal of sensitization was produced by repeated administration of either a D1-class agonist (SKF 81297) or the combination of an NMDA receptor antagonist and a D2-class agonist. Effective combinations were cocaine+MK-801, quinpirole+MK-801, quinpirole+CGS 19755, and pergolide+memantine. The latter drugs are approved for human use. Reversal of sensitization persisted for at least 2 weeks after cessation of drug treatment. Electrophysiological studies revealed that these drug treatments also reversed dopamine D1 receptor supersensitivity in the nucleus accumbens, a cellular correlate of sensitization. Conclusions: These results demonstrate that pharmacotherapy can reverse behavioral and cellular adaptations associated with repeated cocaine administration, and may do so without the need for continued medication.

Original languageEnglish (US)
Pages (from-to)175-183
Number of pages9
JournalPsychopharmacology
Volume151
Issue number2-3
DOIs
StatePublished - Jan 1 2000
Externally publishedYes

Fingerprint

Cocaine
Pharmacology
Quinpirole
Dizocilpine Maleate
selfotel
N-Methyl-D-Aspartate Receptors
Pharmaceutical Preparations
Dopamine
Pergolide
Memantine
Dopamine D1 Receptors
Cocaine-Related Disorders
Withholding Treatment
Dopamine Agonists
Nucleus Accumbens
N-Methylaspartate
Glutamic Acid
Animal Models
Maintenance
Drug Therapy

Keywords

  • Behavioral sensitization
  • Cocaine
  • Drug addiction
  • Memantine
  • NMDA receptor
  • Nucleus accumbens

ASJC Scopus subject areas

  • Pharmacology

Cite this

Pharmacological reversal of behavioral and cellular indices of cocaine sensitization in the rat. / Li, Y.; White, F. J.; Wolf, Marina.

In: Psychopharmacology, Vol. 151, No. 2-3, 01.01.2000, p. 175-183.

Research output: Contribution to journalArticle

@article{597f060fd5c244af8de628dd8e75f492,
title = "Pharmacological reversal of behavioral and cellular indices of cocaine sensitization in the rat",
abstract = "Rationale and objectives: Behavioral sensitization has been proposed as an animal model for the intensification of drug craving in cocaine addiction. Interactions between dopamine and glutamate systems are important for the induction and maintenance of sensitization. The goal of this study was to determine if established cocaine sensitization could be reversed by pharmacological manipulation of these transmitter systems. Methods: Rats received 15 mg/kg cocaine (IP) on days 1-10 and were challenged with cocaine (10 mg/kg) on day 13 to verify that sensitization had occurred. On days 14-20, separate groups of sensitized rats received daily injections of dopamine D1- or D2-class agonists, an NMDA receptor antagonist, or a dopamine agonist with an NMDA antagonist. Three days or 2 weeks later, all rats were again tested for their response to cocaine to determine if sensitization had been reversed. Results: Reversal of sensitization was produced by repeated administration of either a D1-class agonist (SKF 81297) or the combination of an NMDA receptor antagonist and a D2-class agonist. Effective combinations were cocaine+MK-801, quinpirole+MK-801, quinpirole+CGS 19755, and pergolide+memantine. The latter drugs are approved for human use. Reversal of sensitization persisted for at least 2 weeks after cessation of drug treatment. Electrophysiological studies revealed that these drug treatments also reversed dopamine D1 receptor supersensitivity in the nucleus accumbens, a cellular correlate of sensitization. Conclusions: These results demonstrate that pharmacotherapy can reverse behavioral and cellular adaptations associated with repeated cocaine administration, and may do so without the need for continued medication.",
keywords = "Behavioral sensitization, Cocaine, Drug addiction, Memantine, NMDA receptor, Nucleus accumbens",
author = "Y. Li and White, {F. J.} and Marina Wolf",
year = "2000",
month = "1",
day = "1",
doi = "10.1007/s002130000454",
language = "English (US)",
volume = "151",
pages = "175--183",
journal = "Psychopharmacology",
issn = "0033-3158",
publisher = "Springer Verlag",
number = "2-3",

}

TY - JOUR

T1 - Pharmacological reversal of behavioral and cellular indices of cocaine sensitization in the rat

AU - Li, Y.

AU - White, F. J.

AU - Wolf, Marina

PY - 2000/1/1

Y1 - 2000/1/1

N2 - Rationale and objectives: Behavioral sensitization has been proposed as an animal model for the intensification of drug craving in cocaine addiction. Interactions between dopamine and glutamate systems are important for the induction and maintenance of sensitization. The goal of this study was to determine if established cocaine sensitization could be reversed by pharmacological manipulation of these transmitter systems. Methods: Rats received 15 mg/kg cocaine (IP) on days 1-10 and were challenged with cocaine (10 mg/kg) on day 13 to verify that sensitization had occurred. On days 14-20, separate groups of sensitized rats received daily injections of dopamine D1- or D2-class agonists, an NMDA receptor antagonist, or a dopamine agonist with an NMDA antagonist. Three days or 2 weeks later, all rats were again tested for their response to cocaine to determine if sensitization had been reversed. Results: Reversal of sensitization was produced by repeated administration of either a D1-class agonist (SKF 81297) or the combination of an NMDA receptor antagonist and a D2-class agonist. Effective combinations were cocaine+MK-801, quinpirole+MK-801, quinpirole+CGS 19755, and pergolide+memantine. The latter drugs are approved for human use. Reversal of sensitization persisted for at least 2 weeks after cessation of drug treatment. Electrophysiological studies revealed that these drug treatments also reversed dopamine D1 receptor supersensitivity in the nucleus accumbens, a cellular correlate of sensitization. Conclusions: These results demonstrate that pharmacotherapy can reverse behavioral and cellular adaptations associated with repeated cocaine administration, and may do so without the need for continued medication.

AB - Rationale and objectives: Behavioral sensitization has been proposed as an animal model for the intensification of drug craving in cocaine addiction. Interactions between dopamine and glutamate systems are important for the induction and maintenance of sensitization. The goal of this study was to determine if established cocaine sensitization could be reversed by pharmacological manipulation of these transmitter systems. Methods: Rats received 15 mg/kg cocaine (IP) on days 1-10 and were challenged with cocaine (10 mg/kg) on day 13 to verify that sensitization had occurred. On days 14-20, separate groups of sensitized rats received daily injections of dopamine D1- or D2-class agonists, an NMDA receptor antagonist, or a dopamine agonist with an NMDA antagonist. Three days or 2 weeks later, all rats were again tested for their response to cocaine to determine if sensitization had been reversed. Results: Reversal of sensitization was produced by repeated administration of either a D1-class agonist (SKF 81297) or the combination of an NMDA receptor antagonist and a D2-class agonist. Effective combinations were cocaine+MK-801, quinpirole+MK-801, quinpirole+CGS 19755, and pergolide+memantine. The latter drugs are approved for human use. Reversal of sensitization persisted for at least 2 weeks after cessation of drug treatment. Electrophysiological studies revealed that these drug treatments also reversed dopamine D1 receptor supersensitivity in the nucleus accumbens, a cellular correlate of sensitization. Conclusions: These results demonstrate that pharmacotherapy can reverse behavioral and cellular adaptations associated with repeated cocaine administration, and may do so without the need for continued medication.

KW - Behavioral sensitization

KW - Cocaine

KW - Drug addiction

KW - Memantine

KW - NMDA receptor

KW - Nucleus accumbens

UR - http://www.scopus.com/inward/record.url?scp=0033842655&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033842655&partnerID=8YFLogxK

U2 - 10.1007/s002130000454

DO - 10.1007/s002130000454

M3 - Article

C2 - 10972463

AN - SCOPUS:0033842655

VL - 151

SP - 175

EP - 183

JO - Psychopharmacology

JF - Psychopharmacology

SN - 0033-3158

IS - 2-3

ER -